AAO: Applying impact of real-world data on day-to-day practice
Ted Leng, MD, MS, Byers Eye Institute at Stanford, and medical advisor for Verana Health, talks about data insights for retinal surgeons. Steven D. Schwartz, MD, Stein Eye Institute, UCLA, highlights his AAO presentation, “New Insight into Real-World U.S. Injection Data."
Ted Leng, MD, MS, associate professor of ophthalmology with the Byers Eye Institute at Stanford, and medical advisor for Verana Health, talks about data insights for retinal surgeons. Leng is joined by Steven D. Schwartz, MD, the Ahmanson Professor of Ophthalmology and chief-retina division with Stein Eye Institute, UCLA. Schwartz highlights his AAO presentation, “New Insight into Real-World U.S. Injection Data,” which highlights the impact of the coronavirus disease 2019 pandemic on intravitreal injection usage.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
